Scolaris Content Display Scolaris Content Display

Cochrane Central Register of Controlled Trials

Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial

Raffi F, Jaeger H, Quiros‐Roldan E, Albrecht H, Belonosova E, Gatell JM, Baril JG, Domingo P, Brennan C, Almond S, Min S, extended SPRING‐2 Study Group
The lancet. Infectious diseases, 2013, 13(11), 927‐935 | added to CENTRAL: 31 March 2014 | 2014 Issue 3
https://doi.org/10.1016/S1473-3099(13)70257-3
Sourced from:
PubMed
Links: PubMed ClinicalTrials.gov
Unlock the abstract